DiaMedica Therapeutics (DMAC) Receivables - Other (2017 - 2026)
DiaMedica Therapeutics' (DMAC) quarterly Receivables - Other came in at $285000.0 in Q1 2026, up 24.45% year-on-year from $229000.0 in Q1 2025, and up 14.0% quarter-over-quarter from $250000.0 in Q4 2025.
DiaMedica Therapeutics (DMAC) Receivables - Other (2017 - 2026) Analysis & Trends
DiaMedica Therapeutics' Receivables - Other history runs 10 years deep, the most recent figure standing at $285000.0 for Q1 2026.
- On a quarterly basis, Receivables - Other rose 24.45% year-over-year to $285000.0 in Q1 2026; TTM through Mar 2026 was $285000.0, a 24.45% increase from a year earlier, with the FY2025 full-year figure at $250000.0, up 24900.0% from the prior year.
- Receivables - Other rose to $285000.0 in Q1 2026 per DMAC's latest filing, from $250000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $391000.0 in Q1 2024 and bottomed at $1000.0 in Q4 2024.
- The 5-year median for Receivables - Other is $228000.0 (2025), against an average of $188400.0.
- Across the five-year window, Receivables - Other plunged 99.31% in 2022 and surged 24900.0% in 2025, its largest moves.
- Year by year, Receivables - Other stood at $2000.0 in 2022, then soared by 3450.0% to $71000.0 in 2023, then tumbled by 98.59% to $1000.0 in 2024, then jumped by 24900.0% to $250000.0 in 2025, then grew by 14.0% to $285000.0 in 2026.
- Per Business Quant, the three latest DMAC Receivables - Other figures stand at $285000.0 (Q1 2026), $250000.0 (Q4 2025), and $228000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | DiaMedica Therapeutics | 364.72 Mn | 364.72 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 285,000.00 |
| Mar 31, 2026 | 285,000.00 |
| Dec 31, 2025 | 250,000.00 |
| Dec 31, 2025 | 250,000.00 |
| Sep 30, 2025 | 228,000.00 |
| Sep 30, 2025 | 228,000.00 |
| Jun 30, 2025 | 142,000.00 |
| Jun 30, 2025 | 142,000.00 |
| Mar 31, 2025 | 229,000.00 |
| Mar 31, 2025 | 229,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | 288,000.00 |
| Sep 30, 2024 | 288,000.00 |
| Jun 30, 2024 | 387,000.00 |
| Jun 30, 2024 | 387,000.00 |
| Mar 31, 2024 | 391,000.00 |
| Mar 31, 2024 | 391,000.00 |
| Dec 31, 2023 | 71,000.00 |
| Dec 31, 2023 | 71,000.00 |